Express Scripts narrows profit outlook

Express Scripts announced Tuesday a profit of $722.9 million for the third quarter, or $1.15 a share. That figure is up from $661.7 million, or 97 cents a share, a year ago. Per-share profit increased to $1.74 from $1.45 a year ago, excluding certain items.

Express Scripts announced Tuesday a profit of $722.9 million for the third quarter, or $1.15 a share. That figure is up from $661.7 million, or 97 cents a share, a year ago. Per-share profit increased to $1.74 from $1.45 a year ago, excluding certain items. Revenue increase slightly to $25.41 billion, just under analyst estimates of $25.49 billion. The company said it now expects adjusted profit for the year of $6.36 to $6.42 a share, compared with its previous expectations of $6.33 to $6.43. Adjusted fourth-quarter earnings are estimated to range from $1.84 to $1.90 a share, compared with analyst expectations of $1.74 a share, on total claims of 314 million to 329 million. For the third quarter, adjusted claims—which include monthly prescriptions filled in community pharmacies and 90-day fills through Express Scripts' mail-order business—dropped 5% to 312.2 million.